OSI trying drug on early lung cancer
September 29th, 2006
Hoping to beat back lung cancer, researchers at OSI Pharmaceuticals Inc. in Melville plan to study how the company’s Tarceva pill might be used to recast the disease as chronic but manageable in some patients.